Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock …